Stephen V. Liu: How do we encourage colleagues and patients to wait for biomarker results?

Stephen V. Liu shared on X:

“Faced with an urgency to start therapy for newly diagnosed lung cancer, how do we encourage colleagues and patients to wait for biomarker results? Advice from patient advocate Aurora Lucas & Drs. Mark Kris & Ilit Turgeman in this IASLC podcast episode.”

Source: Stephen V. Liu/X

Stephen V. Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered.”